Aqr Capital Management LLC Ultragenyx Pharmaceutical Inc. Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

A detailed history of Aqr Capital Management LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 1,044,373 shares of RARE stock, worth $49.3 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

1,044,373

Previous 97,100 975.56%

Holding current value

$49.3 Million

Previous $3.99 Million 1353.98%

% of portfolio

0.08%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$40.21 - $59.36 $38.1 Million - $56.2 Million	947,273 Added 975.56%	1,044,373 $58 Million
Q2 2024 Aug 14, 2024	SELL	$37.42 - $51.61 $5.77 Million - $7.95 Million	-154,097 Reduced 61.35%	97,100 $3.99 Million
Q1 2024 May 15, 2024	BUY	$43.02 - $53.69 $3.46 Million - $4.32 Million	80,508 Added 47.17%	251,197 $11.7 Million
Q4 2023 Feb 14, 2024	BUY	$31.73 - $49.19 $5.42 Million - $8.4 Million	170,689 New	170,689 $8.16 Million
Q1 2023 May 15, 2023	BUY	$36.99 - $48.71 $739,689 - $974,053	19,997 Added 125.66%	35,911 $1.44 Million
Q4 2022 Feb 14, 2023	BUY	$33.72 - $46.33 $191,934 - $263,710	5,692 Added 55.68%	15,914 $737,000
Q3 2022 Nov 14, 2022	BUY	$39.96 - $66.14 $408,471 - $676,083	10,222 New	10,222 $423,000
Q3 2021 Nov 15, 2021	SELL	$77.92 - $102.4 $740,240 - $972,800	-9,500 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$92.19 - $115.71 $1.78 Million - $2.23 Million	-19,284 Reduced 67.0%	9,500 $906,000
Q1 2021 May 17, 2021	SELL	$106.9 - $167.73 $987,114 - $1.55 Million	-9,234 Reduced 24.29%	28,784 $3.28 Million
Q4 2020 Feb 16, 2021	BUY	$84.4 - $177.39 $756,139 - $1.59 Million	8,959 Added 30.83%	38,018 $5.26 Million
Q3 2020 Nov 16, 2020	BUY	$72.98 - $90.0 $115,016 - $141,840	1,576 Added 5.73%	29,059 $2.39 Million
Q2 2020 Aug 17, 2020	BUY	$46.91 - $78.22 $179,946 - $300,051	3,836 Added 16.22%	27,483 $2.15 Million
Q1 2020 May 15, 2020	BUY	$33.8 - $62.9 $615,836 - $1.15 Million	18,220 Added 335.73%	23,647 $1.05 Million
Q4 2019 Feb 14, 2020	BUY	$36.08 - $45.83 $195,806 - $248,719	5,427 New	5,427 $232,000
Q3 2019 Nov 14, 2019	SELL	$42.5 - $63.11 $309,527 - $459,630	-7,283 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$54.93 - $74.36 $400,055 - $541,563	7,283 New	7,283 $462,000
Q1 2019 May 14, 2019	SELL	$39.87 - $69.36 $313,298 - $545,030	-7,858 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$38.89 - $77.3 $37,956 - $75,444	976 Added 14.18%	7,858 $342,000
Q3 2018 Nov 15, 2018	BUY	$71.81 - $90.15 $494,196 - $620,412	6,882 New	6,882 $525,000

Others Institutions Holding RARE

# of Institutions

325

Shares Held

85.7M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.31B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account

Aqr Capital Management LLC Ultragenyx Pharmaceutical Inc. Transaction History